M N Stojanovic1, P de Prada, D W Landry
1Division of Clinical Pharmacology and Experimental Therapeutics, Department of Medicine, Columbia University, New York, NY 10032, USA. mns18@columbia.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers developed new homogeneous assays using deoxyribozyme ribonuclease activity. These deoxyribozymes, modified with biotin, detect biotin-binding interactions via fluorescence, offering potential as versatile analytical tools.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: